Delayed Referral of Female Patients With Rheumatoid Arthritis: Where Are We Now? A Study Spanning 3 Decades
J Rheumatol
.
2022 Dec;49(12):1402-1403.
doi: 10.3899/jrheum.220429.
Epub 2022 Sep 15.
Authors
Bastiaan T van Dijk
1
,
Annette H M van der Helm-van Mil
2
3
Affiliations
1
Department of Rheumatology, Leiden University Medical Centre, Leiden; B.T.van_Dijk@lumc.nl.
2
Department of Rheumatology, Leiden University Medical Centre, Leiden.
3
Department of Rheumatology, Erasmus Medical Centre, Rotterdam, the Netherlands.
PMID:
36109069
PMCID:
PMC7615875
DOI:
10.3899/jrheum.220429
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Antirheumatic Agents* / therapeutic use
Arthritis, Rheumatoid* / drug therapy
Female
Humans
Referral and Consultation
Substances
Antirheumatic Agents
Grants and funding
714312/ERC_/European Research Council/International